The adverse events of NECT replicate those of nifurtimox and eflornithine monotherapies, but are in general less severe. Suramin is recommended in children aged 6 years or younger or who weigh less ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果